| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-46 |
| filingDate |
1993-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe1a5f7e51eb482ef096317614431409 |
| publicationDate |
1995-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5453431-A |
| titleOfInvention |
Use of hydroxychloroquine for treatment of graft-versus-host disease |
| abstract |
The present invention provides methods of treating graft-versus-host disease comprising administering to a patient having graft-versus-host disease an effective mount of hydroxychloroquine. The present invention aim provides a method of suppressing alloreactivity arising from reactions of donor T lymphocytes against recipient cells comprising administering to said cells an amount of hydroxychloroquine effective to suppress such alloreaetivity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10329258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03039488-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03039488-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004071666-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002363444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009039625-A1 |
| priorityDate |
1993-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |